214 related articles for article (PubMed ID: 10906164)
1. Quantification and longitudinal trends of kidney, renal cyst, and renal parenchyma volumes in autosomal dominant polycystic kidney disease.
King BF; Reed JE; Bergstralh EJ; Sheedy PF; Torres VE
J Am Soc Nephrol; 2000 Aug; 11(8):1505-1511. PubMed ID: 10906164
[TBL] [Abstract][Full Text] [Related]
2. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
[TBL] [Abstract][Full Text] [Related]
3. Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography.
Sise C; Kusaka M; Wetzel LH; Winklhofer F; Cowley BD; Cook LT; Gordon M; Grantham JJ
Kidney Int; 2000 Dec; 58(6):2492-501. PubMed ID: 11115083
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
Torres VE; King BF; Chapman AB; Brummer ME; Bae KT; Glockner JF; Arya K; Risk D; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
Clin J Am Soc Nephrol; 2007 Jan; 2(1):112-20. PubMed ID: 17699395
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.
King BF; Torres VE; Brummer ME; Chapman AB; Bae KT; Glockner JF; Arya K; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
Kidney Int; 2003 Dec; 64(6):2214-21. PubMed ID: 14633145
[TBL] [Abstract][Full Text] [Related]
6. The correlation between kidney volume and measured glomerular filtration rate in an Asian ADPKD population: a prospective cohort study.
Phakdeekitcharoen B; Treesinchai W; Wibulpolprasert P; Boongird S; Klytrayong P
BMC Nephrol; 2021 May; 22(1):178. PubMed ID: 33992075
[TBL] [Abstract][Full Text] [Related]
7. Computed tomography evaluation of autosomal dominant polycystic kidney disease progression: a progress report.
Antiga L; Piccinelli M; Fasolini G; Ene-Iordache B; Ondei P; Bruno S; Remuzzi G; Remuzzi A
Clin J Am Soc Nephrol; 2006 Jul; 1(4):754-60. PubMed ID: 17699283
[TBL] [Abstract][Full Text] [Related]
8. Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations.
Spithoven EM; Meijer E; Boertien WE; Sinkeler SJ; Tent H; de Jong PE; Navis G; Gansevoort RT
Am J Kidney Dis; 2013 Sep; 62(3):531-40. PubMed ID: 23714171
[TBL] [Abstract][Full Text] [Related]
9. Automatic Segmentation of Kidneys using Deep Learning for Total Kidney Volume Quantification in Autosomal Dominant Polycystic Kidney Disease.
Sharma K; Rupprecht C; Caroli A; Aparicio MC; Remuzzi A; Baust M; Navab N
Sci Rep; 2017 May; 7(1):2049. PubMed ID: 28515418
[TBL] [Abstract][Full Text] [Related]
10. Kidney Function Reserve Capacity in Early and Later Stage Autosomal Dominant Polycystic Kidney Disease.
Messchendorp AL; van Londen M; Taylor JM; de Borst MH; Navis G; Casteleijn NF; Gaillard CAJM; Bakker SJL; Gansevoort RT;
Clin J Am Soc Nephrol; 2018 Nov; 13(11):1680-1692. PubMed ID: 30254028
[TBL] [Abstract][Full Text] [Related]
11. Polycystic liver disease: quantitation of parenchymal and cyst volumes from computed tomography images and clinical correlates of hepatic cysts.
Everson GT; Scherzinger A; Berger-Leff N; Reichen J; Lezotte D; Manco-Johnson M; Gabow P
Hepatology; 1988; 8(6):1627-34. PubMed ID: 3192176
[TBL] [Abstract][Full Text] [Related]
12. Hemorrhagic Cysts and Other MR Biomarkers for Predicting Renal Dysfunction Progression in Autosomal Dominant Polycystic Kidney Disease.
Riyahi S; Dev H; Blumenfeld JD; Rennert H; Yin X; Attari H; Barash I; Chicos I; Bobb W; Donahue S; Prince MR
J Magn Reson Imaging; 2021 Feb; 53(2):564-576. PubMed ID: 32969110
[TBL] [Abstract][Full Text] [Related]
13. Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: a longitudinal study.
Fick-Brosnahan GM; Belz MM; McFann KK; Johnson AM; Schrier RW
Am J Kidney Dis; 2002 Jun; 39(6):1127-34. PubMed ID: 12046022
[TBL] [Abstract][Full Text] [Related]
14. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
[TBL] [Abstract][Full Text] [Related]
15. Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease.
Helal I; Reed B; McFann K; Yan XD; Fick-Brosnahan GM; Cadnapaphornchai M; Schrier RW
Clin J Am Soc Nephrol; 2011 Oct; 6(10):2439-43. PubMed ID: 21903987
[TBL] [Abstract][Full Text] [Related]
16. [Effect of a simple kidney cyst on renal function].
Malkhasyan VA; Makhmudov TB; Gilfanov YS; Semenyakin IV; Sukhikh SO; Pushkar DY
Urologiia; 2023 Sep; (4):75-81. PubMed ID: 37850285
[TBL] [Abstract][Full Text] [Related]
17. A Review of the Imaging Techniques for Measuring Kidney and Cyst Volume in Establishing Autosomal Dominant Polycystic Kidney Disease Progression.
Magistroni R; Corsi C; Martí T; Torra R
Am J Nephrol; 2018; 48(1):67-78. PubMed ID: 30071518
[TBL] [Abstract][Full Text] [Related]
18. Volume progression in polycystic kidney disease.
Grantham JJ; Torres VE; Chapman AB; Guay-Woodford LM; Bae KT; King BF; Wetzel LH; Baumgarten DA; Kenney PJ; Harris PC; Klahr S; Bennett WM; Hirschman GN; Meyers CM; Zhang X; Zhu F; Miller JP;
N Engl J Med; 2006 May; 354(20):2122-30. PubMed ID: 16707749
[TBL] [Abstract][Full Text] [Related]
19. Automated Segmentation of Kidneys from MR Images in Patients with Autosomal Dominant Polycystic Kidney Disease.
Kim Y; Ge Y; Tao C; Zhu J; Chapman AB; Torres VE; Yu AS; Mrug M; Bennett WM; Flessner MF; Landsittel DP; Bae KT;
Clin J Am Soc Nephrol; 2016 Apr; 11(4):576-84. PubMed ID: 26797708
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of long-acting somatostatin treatment in autosomal-dominant polycystic kidney disease.
Ruggenenti P; Remuzzi A; Ondei P; Fasolini G; Antiga L; Ene-Iordache B; Remuzzi G; Epstein FH
Kidney Int; 2005 Jul; 68(1):206-16. PubMed ID: 15954910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
